Status:
COMPLETED
A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis
Lead Sponsor:
Amgen
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The overall objective of the study is to assess the effectiveness of switching from immediate-release prednisone (conventional) therapy to delayed-release prednisone (RAYOS) in patients with moderatel...
Detailed Description
Adult Rheumatoid Arthritis (RA) participants previously receiving immediate release prednisone were enrolled in the trial if they and their physicians both consented. Once entered, participant baselin...
Eligibility Criteria
Inclusion
- Age ≥ 18 and in general good health (Investigator discretion) with a recent stable medical history other than related to RA disease activity
- RA diagnosis is ≥ 6 months according to ACR and/or EULAR classification criteria for diagnosis of active RA
- Morning stiffness duration of at least 45 minutes at study entry
- RA disease activity as defined by DAS28 of ≥ 3.2 at study entry
- Currently receiving conventional immediate-release prednisone ≥ 2.5 milligram (mg) every morning and previously agreed to switch to RAYOS
- Willing and able to sign an Informed Consent Form (ICF)
Exclusion
- Patient is unwilling to participate in the non-interventional study
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT02287610
Start Date
November 1 2014
End Date
October 1 2015
Last Update
December 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.